193 related articles for article (PubMed ID: 11718162)
1. Treatment of rheumatoid arthritis: unknown long-term effects.
Prescrire Int; 2001 Apr; 10(52):55-61. PubMed ID: 11718162
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
[TBL] [Abstract][Full Text] [Related]
3. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
Schiff MH; Whelton A
Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.
Prescrire Int; 2004 Oct; 13(73):171-5. PubMed ID: 15499697
[TBL] [Abstract][Full Text] [Related]
5. Etanercept: new preparation. Useful after methotrexate failure in inflammatory rheumatism.
Prescrire Int; 2003 Aug; 12(66):127-32. PubMed ID: 12906020
[TBL] [Abstract][Full Text] [Related]
6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
7. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
[TBL] [Abstract][Full Text] [Related]
9. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
10. Infliximab therapy in established rheumatoid arthritis: an observational study.
Voulgari PV; Alamanos Y; Nikas SN; Bougias DV; Temekonidis TI; Drosos AA
Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254
[TBL] [Abstract][Full Text] [Related]
11. [Armentarium and strategies for the treatment of rheumatoid arthritis].
Lioté F
Rev Prat; 2005 Dec; 55(19):2146-60. PubMed ID: 16544925
[TBL] [Abstract][Full Text] [Related]
12. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.
Kinder AJ; Hassell AB; Brand J; Brownfield A; Grove M; Shadforth MF
Rheumatology (Oxford); 2005 Jan; 44(1):61-6. PubMed ID: 15611303
[TBL] [Abstract][Full Text] [Related]
13. [Combination therapy of rheumatoid arthritis].
Hansen A; Jensen T
Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
[TBL] [Abstract][Full Text] [Related]
14. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
Capell H; McCarey D; Madhok R; Hampson R
J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
[TBL] [Abstract][Full Text] [Related]
15. Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.
Conaghan PG; Brooks P
Curr Opin Rheumatol; 1996 May; 8(3):176-82. PubMed ID: 8796975
[TBL] [Abstract][Full Text] [Related]
16. What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?
March L; Lapsley H
Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):171-85. PubMed ID: 11358421
[TBL] [Abstract][Full Text] [Related]
17. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of rheumatoid arthritis (chronic polyarthritis)].
Villiger PM; Stucki G
Praxis (Bern 1994); 1996 Sep; 85(37):1102-7. PubMed ID: 8927885
[TBL] [Abstract][Full Text] [Related]
19. Therapy insight: the use of antirheumatic drugs during nursing.
Østensen M; Motta M
Nat Clin Pract Rheumatol; 2007 Jul; 3(7):400-6. PubMed ID: 17599074
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of rheumatoid arthritis].
Babić-Naglić D
Reumatizam; 2003; 50(2):22-7. PubMed ID: 15098369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
